{"id":"https://openalex.org/W4404635682","doi":"https://doi.org/10.1016/j.yrtph.2024.105743","title":"Carcinogenicity assessment of inotersen in Tg.rasH2 mice and Sprague-Dawley rats: Implications for 2\u2032-MOE antisense oligonucleotides","display_name":"Carcinogenicity assessment of inotersen in Tg.rasH2 mice and Sprague-Dawley rats: Implications for 2\u2032-MOE antisense oligonucleotides","publication_year":2024,"publication_date":"2024-11-22","ids":{"openalex":"https://openalex.org/W4404635682","doi":"https://doi.org/10.1016/j.yrtph.2024.105743","pmid":"https://pubmed.ncbi.nlm.nih.gov/39580013"},"language":"en","primary_location":{"id":"doi:10.1016/j.yrtph.2024.105743","doi":"https://doi.org/10.1016/j.yrtph.2024.105743","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yrtph.2024.105743","pdf_url":null,"source":{"id":"https://openalex.org/S87719511","display_name":"Regulatory Toxicology and Pharmacology","issn_l":"0273-2300","issn":["0273-2300","1096-0295"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regulatory Toxicology and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.yrtph.2024.105743","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100745448","display_name":"Tae\u2010Won Kim","orcid":"https://orcid.org/0000-0002-5239-3833","observed_orcids":["https://orcid.org/0000-0002-5239-3833","https://orcid.org/0009-0002-7244-8149"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tae-Won Kim","raw_affiliation_strings":["Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. Electronic address: tkim@ionis.com","Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010. Electronic address: tkim@ionis.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. Electronic address: tkim@ionis.com","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010. Electronic address: tkim@ionis.com","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090129585","display_name":"Chris N. Papagiannis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126295","display_name":"Charles River Laboratories (United States)","ror":"https://ror.org/03ndmsg87","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris N. Papagiannis","raw_affiliation_strings":["Charles River Laboratories, 54943 N Main St, Mattawan, MI, 49071, USA","Charles River Laboratories, 54943 N Main St, Mattawan, MI 49071"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles River Laboratories, 54943 N Main St, Mattawan, MI, 49071, USA","institution_ids":["https://openalex.org/I4210126295"]},{"raw_affiliation_string":"Charles River Laboratories, 54943 N Main St, Mattawan, MI 49071","institution_ids":["https://openalex.org/I4210126295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035236024","display_name":"Laura S. Zwick","orcid":"https://orcid.org/0000-0001-6517-7227","observed_orcids":["https://orcid.org/0000-0001-6517-7227"]},"institutions":[{"id":"https://openalex.org/I276601970","display_name":"Zoetis (United States)","ror":"https://ror.org/03k2dnh74","country_code":"US","type":"company","lineage":["https://openalex.org/I276601970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura S. Zwick","raw_affiliation_strings":["Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA","Zoetis, 333 Portage Street, Kalamazoo, MI 49007"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA","institution_ids":[]},{"raw_affiliation_string":"Zoetis, 333 Portage Street, Kalamazoo, MI 49007","institution_ids":["https://openalex.org/I276601970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009558693","display_name":"Paul W. Snyder","orcid":"https://orcid.org/0000-0002-0444-2426","observed_orcids":["https://orcid.org/0000-0002-0444-2426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Snyder","raw_affiliation_strings":["EPL Midwest, 1305 Cumberland Ave. Ste. 200, West Lafayette, IN, 47906, USA","EPL Midwest, 1305 Cumberland Ave. Ste. 200, West Lafayette, IN 47906"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPL Midwest, 1305 Cumberland Ave. Ste. 200, West Lafayette, IN, 47906, USA","institution_ids":[]},{"raw_affiliation_string":"EPL Midwest, 1305 Cumberland Ave. Ste. 200, West Lafayette, IN 47906","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028565067","display_name":"Jeffery A. Engelhardt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffery A. Engelhardt","raw_affiliation_strings":["Engelhardt Consulting, Carlsbad, CA, USA","Engelhardt Consulting, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Engelhardt Consulting, Carlsbad, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Engelhardt Consulting, Carlsbad, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002446366","display_name":"Rosie Z. Yu","orcid":"https://orcid.org/0000-0001-9266-7280","observed_orcids":["https://orcid.org/0000-0001-9266-7280"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosie Z. Yu","raw_affiliation_strings":["Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048836592","display_name":"Christine M. Hoffmaster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine M. Hoffmaster","raw_affiliation_strings":["Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084582427","display_name":"Archit Rastogi","orcid":"https://orcid.org/0000-0002-2572-3227","observed_orcids":["https://orcid.org/0000-0002-2572-3227"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Archit Rastogi","raw_affiliation_strings":["Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010"],"raw_orcid":"https://orcid.org/0000-0002-2572-3227","affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083254716","display_name":"Scott P. Henry","orcid":"https://orcid.org/0000-0001-5817-0369","observed_orcids":["https://orcid.org/0000-0001-5817-0369"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott P. Henry","raw_affiliation_strings":["Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals, inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Ionis Pharmaceuticals, inc. 2855 Gazelle Court, Carlsbad, CA 92010","institution_ids":["https://openalex.org/I2800035258"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100745448"],"corresponding_institution_ids":["https://openalex.org/I2800035258"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":{"value":3950,"currency":"USD","value_usd":3950},"fwci":0.1519,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.46227669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"155","issue":null,"first_page":"105743","last_page":"105743"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.1339000016450882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0786999985575676,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inotersen","display_name":"inotersen","score":1.0},{"id":"https://openalex.org/keywords/carcinogenicity","display_name":"carcinogenicity","score":0.9020000100135803},{"id":"https://openalex.org/keywords/sprague-dawley-rats","display_name":"Sprague-Dawley rats","score":0.9240000247955322},{"id":"https://openalex.org/keywords/chronic-progressive-nephropathy","display_name":"chronic progressive nephropathy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/familial-amyloid-polyneuropathy","display_name":"hereditary transthyretin amyloidosis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.5360000133514404},{"id":"https://openalex.org/keywords/proinflammatory-effects","display_name":"pro-inflammatory effects","score":0.6110000014305115},{"id":"https://openalex.org/keywords/nonclinical-safety-evaluation","display_name":"nonclinical safety evaluation","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.7436522245407104},{"id":"https://openalex.org/C114246631","wikidata":"https://www.wikidata.org/wiki/Q187661","display_name":"Carcinogen","level":2,"score":0.6682505011558533},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47563600540161133},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4234827160835266},{"id":"https://openalex.org/C33070731","wikidata":"https://www.wikidata.org/wiki/Q7218","display_name":"Toxicology","level":1,"score":0.3650679886341095},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36399146914482117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31259027123451233},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20962324738502502},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.13683441281318665}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015197","descriptor_name":"Carcinogenicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015197","descriptor_name":"Carcinogenicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015197","descriptor_name":"Carcinogenicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.yrtph.2024.105743","doi":"https://doi.org/10.1016/j.yrtph.2024.105743","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yrtph.2024.105743","pdf_url":null,"source":{"id":"https://openalex.org/S87719511","display_name":"Regulatory Toxicology and Pharmacology","issn_l":"0273-2300","issn":["0273-2300","1096-0295"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regulatory Toxicology and Pharmacology","raw_type":"journal-article"},{"id":"pmid:39580013","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39580013","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regulatory toxicology and pharmacology : RTP","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.yrtph.2024.105743","doi":"https://doi.org/10.1016/j.yrtph.2024.105743","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yrtph.2024.105743","pdf_url":null,"source":{"id":"https://openalex.org/S87719511","display_name":"Regulatory Toxicology and Pharmacology","issn_l":"0273-2300","issn":["0273-2300","1096-0295"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regulatory Toxicology and Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","score":0.5099999904632568,"display_name":"Zero hunger"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314430","display_name":"Ionis Pharmaceuticals","ror":"https://ror.org/00t8bew53"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W60332729","https://openalex.org/W113479637","https://openalex.org/W1891796305","https://openalex.org/W1973170228","https://openalex.org/W1983870655","https://openalex.org/W1997090741","https://openalex.org/W2018702562","https://openalex.org/W2020523402","https://openalex.org/W2076772756","https://openalex.org/W2111312427","https://openalex.org/W2115666606","https://openalex.org/W2119647665","https://openalex.org/W2133816417","https://openalex.org/W2143700830","https://openalex.org/W2146498844","https://openalex.org/W2149353337","https://openalex.org/W2162510215","https://openalex.org/W2166941627","https://openalex.org/W2168966191","https://openalex.org/W2199765595","https://openalex.org/W2316265097","https://openalex.org/W2325373098","https://openalex.org/W2415722141","https://openalex.org/W2473879127","https://openalex.org/W2485758932","https://openalex.org/W2552406570","https://openalex.org/W2788969046","https://openalex.org/W2809989268","https://openalex.org/W2905893839","https://openalex.org/W2948364217","https://openalex.org/W3120856663","https://openalex.org/W4321782374","https://openalex.org/W6643503914","https://openalex.org/W6681882354"],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W161652093","https://openalex.org/W2042073451","https://openalex.org/W2840367830","https://openalex.org/W1998898023","https://openalex.org/W2041390973","https://openalex.org/W2030108052","https://openalex.org/W2159038264","https://openalex.org/W2443952664","https://openalex.org/W2027177155"],"abstract_inverted_index":{"Inotersen,":[0],"a":[1,20,64,249,252],"2'-O-(2-methoxyethyl)":[2],"modified":[3],"antisense":[4],"oligonucleotide":[5],"(2'-MOE":[6],"ASO),":[7],"is":[8,216,272],"approved":[9],"for":[10,205,278],"the":[11,57,90,107,117,157,169,177,208,221,257,268],"treatment":[12],"of":[13,146,186,211,224,235],"hereditary":[14],"transthyretin-mediated":[15],"amyloidosis":[16],"(hATTR).":[17],"It":[18],"underwent":[19],"comprehensive":[21],"nonclinical":[22],"safety":[23,26],"evaluation,":[24],"including":[25],"pharmacology,":[27],"repeat-dose":[28],"toxicity,":[29,34],"genotoxicity,":[30],"reproductive":[31],"and":[32,35,51,63,80,86,92,226,270],"development":[33],"carcinogenicity":[36,44,121,254],"studies.":[37],"Tumorigenic":[38],"potential":[39,277],"was":[40,124,142,166,232],"assessed":[41],"through":[42],"dedicated":[43],"studies":[45,266],"in":[46,89,198,214,237,240,256,267],"transgenic":[47],"rasH2":[48],"(Tg.rasH2)":[49],"mice":[50],"Sprague":[52],"Dawley":[53],"(SD)":[54],"rats.":[55],"In":[56,116],"26-week":[58],"Tg.rasH2":[59,258],"mouse":[60,108],"study,":[61,122],"inotersen":[62,123,201],"mouse-active":[65],"surrogate":[66,109],"(ISIS":[67],"401724)":[68],"were":[69,98,104,180],"administered":[70,125,200],"as":[71,126],"weekly":[72,127],"subcutaneous":[73,187],"(SC)":[74],"doses":[75,129,139,190],"up":[76,130],"to":[77,131,153,182,220,274],"80":[78],"mg/kg":[79],"30":[81],"mg/kg,":[82],"respectively.":[83],"Proinflammatory":[84],"effects":[85,213],"ASO":[87,212,222],"accumulation":[88],"liver":[91],"kidney,":[93],"both":[94],"well-documented":[95],"class":[96],"effects,":[97],"observed;":[99],"however,":[100],"no":[101,163,233],"treatment-related":[102,114],"neoplasms":[103],"noted.":[105],"Similarly,":[106],"did":[110],"not":[111],"induce":[112],"any":[113],"neoplasms.":[115],"2-year":[118],"SD":[119],"rat":[120],"SC":[128],"6":[132,158],"mg/kg.":[133],"The":[134],"primary":[135],"dose-limiting":[136],"effect":[137],"at":[138,156,176,189,242],"\u22652":[140,191],"mg/kg/week":[141,159],"an":[143,183],"increased":[144,170,184],"incidence":[145,185],"chronic":[147,264],"progressive":[148],"nephropathy":[149],"(CPN),":[150],"which":[151],"contributed":[152],"decreased":[154],"survival":[155],"dose":[160],"level.":[161],"Notably,":[162],"renal":[164],"neoplasia":[165],"associated":[167],"with":[168,261],"CPN.":[171],"Increasing":[172],"mononuclear":[173],"cell":[174],"infiltrates":[175],"injection":[178,195],"site":[179,196],"linked":[181],"fibrosarcoma":[188],"mg/kg/week.":[192],"This":[193],"inflammation-associated":[194],"tumor":[197],"rats":[199,215],"has":[202],"limited":[203,218],"relevance":[204],"humans.":[206],"Additionally,":[207],"long-term":[209],"assessment":[210,255],"somewhat":[217],"due":[219],"exacerbation":[223],"CPN":[225],"its":[227],"impact":[228],"on":[229],"survival.":[230],"There":[231],"evidence":[234],"genotoxicity":[236],"vitro":[238],"or":[239],"vivo":[241],"limit":[243],"doses.":[244],"Collectively,":[245],"these":[246],"data":[247,262],"support":[248],"conclusion":[250],"that":[251],"single":[253],"mouse,":[259],"along":[260],"from":[263],"toxicology":[265],"rodent":[269],"nonrodent,":[271],"sufficient":[273],"assess":[275],"carcinogenic":[276],"this":[279],"drug":[280],"class.":[281]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}